Literature DB >> 17543146

Cytokine patterns in fibromyalgia and their correlation with clinical manifestations.

L Bazzichi1, A Rossi, G Massimetti, G Giannaccini, T Giuliano, F De Feo, A Ciapparelli, L Dell'Osso, S Bombardieri.   

Abstract

OBJECTIVE: To examine the possible role of the soluble factor in fibromyalgia (FM) by studying the correlation of cytokine levels with the patients' clinical and psychiatric profile.
METHODS: Eighty FM patients underwent clinical and psychiatric evaluations, and plasma levels of cytokines (IL-1, IL-6, IL-8, IL-10, TNF-alpha), aspecific markers of inflammation, rheumatoid factor (RF), anti-extractable nuclear antigen (ENA) antibodies, and anti-nuclear factor (FAN) were measured.
RESULTS: Higher levels of IL-10, IL-8 and TNF-alpha were found in FM patients than in controls. Significant correlations between the biochemical parameters and clinical data were found.
CONCLUSION: The higher levels of cytokines found in FM patients suggest the presence of an inflammatory response system (IRS) and highlight a parallel between the clinical symptoms and biochemical data. They support the hypothesis that cytokines may play a role in the clinical features of fibromyalgia. In addition, the similar cytokine patterns found in FM patients with different psychiatric profiles suggests that IRS impairment may play a specific role in the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17543146

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  68 in total

1.  The IL-1Ra gene variable number tandem repeat variant is associated with susceptibility to temporomandibular disorders in Turkish population.

Authors:  Mehmet Kemal Tumer; Ayse Feyda Nursal; Akin Tekcan; Kaan Yerliyurt; Anastasia Geyko; Serbulent Yigit
Journal:  J Clin Lab Anal       Date:  2017-06-14       Impact factor: 2.352

Review 2.  Oral Complications of Chronic Graft-Versus-Host Disease.

Authors:  Jane M Fall-Dickson; Steven Z Pavletic; Jacqueline W Mays; Mark M Schubert
Journal:  J Natl Cancer Inst Monogr       Date:  2019-08-01

3.  Decreased olfactory bulb volumes in patients with fibromyalgia syndrome.

Authors:  Selçuk Sayılır; Neşat Çullu
Journal:  Clin Rheumatol       Date:  2017-07-26       Impact factor: 2.980

4.  High frequency and intensity of drinking may attenuate increased inflammatory cytokine levels of major depression in alcohol-use disorders.

Authors:  Sudan P Neupane; Lars Lien; Priscilla Martinez; Pål Aukrust; Thor Ueland; Tom E Mollnes; Knut Hestad; Jørgen G Bramness
Journal:  CNS Neurosci Ther       Date:  2014-07-03       Impact factor: 5.243

5.  Further validation of a model of fibromyalgia syndrome in the rat.

Authors:  Paul G Green; Pedro Alvarez; Robert W Gear; Dennis Mendoza; Jon D Levine
Journal:  J Pain       Date:  2011-04-09       Impact factor: 5.820

6.  Proinflammatory cytokine levels in fibromyalgia patients are independent of body mass index.

Authors:  Maria E Hernandez; Enrique Becerril; Mayra Perez; Philippe Leff; Benito Anton; Sergio Estrada; Iris Estrada; Manuel Sarasa; Enrique Serrano; Lenin Pavon
Journal:  BMC Res Notes       Date:  2010-06-03

7.  Toward characterization and definition of fibromyalgia severity.

Authors:  Stuart Silverman; Alesia Sadosky; Chris Evans; Yating Yeh; Jose Ma J Alvir; Gergana Zlateva
Journal:  BMC Musculoskelet Disord       Date:  2010-04-08       Impact factor: 2.362

Review 8.  Integrated review of the association of cytokines with fibromyalgia and fibromyalgia core symptoms.

Authors:  Victoria Menzies; Debra E Lyon
Journal:  Biol Res Nurs       Date:  2009-11-22       Impact factor: 2.522

9.  Association between fibromyalgia and adverse perioperative outcomes.

Authors:  B D Hesler; J E Dalton; H Singh; P Chahar; L Saager; D I Sessler; A Turan
Journal:  Br J Anaesth       Date:  2014-06-25       Impact factor: 9.166

Review 10.  Fibromyalgia: an update and immunological aspects.

Authors:  Eduardo S Paiva; Evelin Diana Goldenberg Mariano da Costa; Morton Scheinberg
Journal:  Curr Pain Headache Rep       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.